These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 21570153)
1. Clinicohistopathological correlations in juvenile localized scleroderma: studies on a subset of children with hypopigmented juvenile localized scleroderma due to loss of epidermal melanocytes. Sung JJ; Chen TS; Gilliam AC; McCalmont TH; Gilliam AE J Am Acad Dermatol; 2011 Aug; 65(2):364-373. PubMed ID: 21570153 [TBL] [Abstract][Full Text] [Related]
2. Connective tissue nevus misdiagnosed as juvenile localized scleroderma. Tirelli F; Giraudo C; Soliani M; Calabrese F; Martini G; Gisondi P; Meneghel A; Zulian F Pediatr Rheumatol Online J; 2023 Oct; 21(1):125. PubMed ID: 37848914 [TBL] [Abstract][Full Text] [Related]
3. Systematic Review of Health-Related Quality of Life Impact in Juvenile Localized Scleroderma. Sanchez-Espino LF; Luca N; Pope E; Laxer RM; Knight AM; Sibbald C Arthritis Care Res (Hoboken); 2024 Mar; 76(3):340-349. PubMed ID: 37750181 [TBL] [Abstract][Full Text] [Related]
4. Juvenile Scleroderma-What has Changed in the Meantime? Adrovic A; Sahin S; Barut K; Kasapcopur O Curr Rheumatol Rev; 2018; 14(3):219-225. PubMed ID: 29692255 [TBL] [Abstract][Full Text] [Related]
5. [Morphea or juvenile localised scleroderma: Case report]. Strickler A; Gallo S; Jaramillo P; de Toro G Rev Chil Pediatr; 2016; 87(4):279-83. PubMed ID: 26976080 [TBL] [Abstract][Full Text] [Related]
6. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Zulian F; Athreya BH; Laxer R; Nelson AM; Feitosa de Oliveira SK; Punaro MG; Cuttica R; Higgins GC; Van Suijlekom-Smit LW; Moore TL; Lindsley C; Garcia-Consuegra J; Esteves Hilário MO; Lepore L; Silva CA; Machado C; Garay SM; Uziel Y; Martini G; Foeldvari I; Peserico A; Woo P; Harper J; Rheumatology (Oxford); 2006 May; 45(5):614-20. PubMed ID: 16368732 [TBL] [Abstract][Full Text] [Related]
7. Overview of Juvenile localized scleroderma and its management. Li SC; Zheng RJ World J Pediatr; 2020 Feb; 16(1):5-18. PubMed ID: 31786801 [TBL] [Abstract][Full Text] [Related]
8. Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review. Martini G; Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F Autoimmun Rev; 2018 Jul; 17(7):727-734. PubMed ID: 29729451 [TBL] [Abstract][Full Text] [Related]
9. Sarcopenia in juvenile localized scleroderma: new insights on deep involvement. Flores Quispe SKJ; Cavaliere A; Weber M; Stramare R; Zuliani M; Quaia E; Zulian F; Giraudo C Eur Radiol; 2020 Jul; 30(7):4091-4097. PubMed ID: 32144460 [TBL] [Abstract][Full Text] [Related]
10. Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma. Agazzi A; Fadanelli G; Vittadello F; Zulian F; Martini G Pediatr Rheumatol Online J; 2018 Jun; 16(1):37. PubMed ID: 29914516 [TBL] [Abstract][Full Text] [Related]
11. Localized scleroderma: clinical and epidemiological features with emphasis on adulthood- versus childhood-onset disease differences. Lis-Święty A; Skrzypek-Salamon A; Ranosz-Janicka I; Brzezińska-Wcisło L J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1595-1603. PubMed ID: 28271552 [TBL] [Abstract][Full Text] [Related]
12. New developments in juvenile systemic and localized scleroderma. Foeldvari I Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860 [TBL] [Abstract][Full Text] [Related]
13. Esophageal abnormalities in juvenile localized scleroderma: is it associated with other extracutaneous manifestations? Valões CCM; Novak GV; Brunelli JB; Kozu KT; Toma RK; Silva CA Rev Bras Reumatol Engl Ed; 2017; 57(6):521-525. PubMed ID: 29173689 [TBL] [Abstract][Full Text] [Related]
14. Development of minimum standards of care for juvenile localized scleroderma. Constantin T; Foeldvari I; Pain CE; Pálinkás A; Höger P; Moll M; Nemkova D; Weibel L; Laczkovszki M; Clements P; Torok KS Eur J Pediatr; 2018 Jul; 177(7):961-977. PubMed ID: 29728839 [TBL] [Abstract][Full Text] [Related]
15. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]. Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive understanding of idiopathic guttate hypomelanosis: clinical and histopathological correlation. Kim SK; Kim EH; Kang HY; Lee ES; Sohn S; Kim YC Int J Dermatol; 2010 Feb; 49(2):162-6. PubMed ID: 20465639 [TBL] [Abstract][Full Text] [Related]
17. Scleroderma in children: an update. Zulian F; Cuffaro G; Sperotto F Curr Opin Rheumatol; 2013 Sep; 25(5):643-50. PubMed ID: 23912318 [TBL] [Abstract][Full Text] [Related]
19. Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma. Li SC; Higgins GC; Chen M; Torok KS; Rabinovich CE; Stewart K; Laxer RM; Pope E; Haines KA; Punaro M; O'Neil KM; Rheumatology (Oxford); 2021 Dec; 60(12):5724-5733. PubMed ID: 33711155 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular assessment of asymptomatic patients with juvenile-onset localized and systemic scleroderma: 10 years prospective observation. Borowiec A; Dabrowski R; Wozniak J; Jasek S; Chwyczko T; Kowalik I; Musiej-Nowakowska E; Szwed H Scand J Rheumatol; 2012 Feb; 41(1):33-8. PubMed ID: 22103465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]